Model Architecture

The DNAI Pipeline Explorer

Interactive visualization of our complete multi-omics to evolutionary dynamics pipeline. Click any model for detailed architecture, metrics, and specifications.

11
Models
328
Latent Dims
40+
Validation Metrics
31
E2E Tests

Interactive Pipeline Diagram

Hover over models to see connections. Click to explore detailed specifications.

FoundationTransfer (Path B)V1 Pipeline — Static AnalysisV2 Pipeline — Dynamic SimulationMulti-omicsPath A (direct)Path BFoundationMulti-modal VAEv5.10TransferDSNv1.0V1 (Static)CausalDriver-GATv1.0V1 (Static)TxResponsev1.0V2 (Dynamic)Hypernetworkv3.2V2 (Dynamic)Neural ODEv1.0V2 (Dynamic)EvoSimv1.0Predictions
Foundation
Transfer
V1 Static
V2 Dynamic
Hover to explore · Click for details

All Models

Deep dive into each component of the DNAI pipeline

Foundationv5.10

Multi-modal VAE

Compresses a patient's full molecular profile into a biological fingerprint

Prolif Correlation
0.96
Orthogonality (R²)
< 0.001
4 inputs2 outputs
Transferv1.0

Domain Separation Network

Translates mouse model data into human-relevant predictions

Domain Accuracy
~0.55
Cancer Subtype Acc
> 0.90
1 inputs3 outputs
V1 (Static)v1.0

CausalDriver-GAT

Identifies which mutations are actually driving the cancer

AUROC
0.9334
AUPRC
0.9902
3 inputs3 outputs
V1 (Static)v1.0

TxResponse

Predicts how sensitive a tumor is to different drugs

Phase 1 (GDSC)
Complete
Phase 2 (CORAL)
Complete
3 inputs3 outputs
V2 (Dynamic)v3.2

Hypernetwork

Generates personalized tumor parameters for each patient

Global C-index (Path A)
0.7042
Stratified C-index (Path A)
0.6701
4 inputs6 outputs
V2 (Dynamic)v1.0

Neural ODE

Simulates how a tumor responds to treatment over time

PDX Validation R²
0.91
Emulator Fidelity
0.997
5 inputs3 outputs
V2 (Dynamic)v1.0

EvoSim

ODE-coupled stochastic ensemble for clonal evolution under treatment

Clone Diversity
Realistic
Mutation Timing
Validated
4 inputs6 outputs
Treatment Designv1.0

Treatment Optimizer

Ranks treatment regimens using counterfactual reasoning

Phase 1 Spearman ρ
0.727
Phase 2 C-index
0.715
3 inputs3 outputs
Treatment Designv1.1

Synthetic Lethality Engine

Identifies druggable vulnerabilities from mutation-pathway interactions

SL Pairs
28
Unit Tests
37/37
3 inputs3 outputs
Treatment Designv1.1

Immunogenic Variant Candidates

Prioritizes variants for immunotherapy based on tumor microenvironment

Unit Tests
34/34
TME Hallmarks
11
4 inputs3 outputs
Treatment Designv1.0

Methylation Decoder

Reconstructs epigenetic patterns and detects silenced tumor suppressors

Reconstruction R²
0.519 (point) / 0.762 (regional)
PCA Ceiling
0.706
2 inputs3 outputs
Treatment Designv1.0

Combination Discovery Engine

Predicts synergistic drug combinations from monotherapy data alone

Combination Validation
ρ = 0.800
Leave-Target-Family-Out
ρ = 0.689
4 inputs3 outputs

End-to-End Data Flow

From raw multi-omics data to evolutionary predictions in one unified pipeline

Multi-Omics Input

  • RNA-seq (2,579 genes)
  • CNV (1,886 genes)
  • Mutations (500 genes)
  • Methylation (1,000 probes)

Foundation Model

VAE encodes to 328-dimensional latent space with biological structure and interpretability

Dual Pipeline

V1 static analysis + V2 dynamic simulation working in parallel for comprehensive insights

Predictions

  • Driver mutations
  • Drug sensitivity
  • Clone trajectories
  • Evolution risk

Ready to explore the details?

Click any model above to see full architecture specifications, mathematical formulations, and validation metrics.